Long-term recurrence rate after treatment of Helicobacter pylori infection in children and adolescents in Estonia

Scandinavian Journal of Gastroenterology

Volumn 39, Issue 12, 2004, Pages 1186-1191

  Oona, Marje ^a   Rago T ^a   Maaroos, H I ^a  

^a NONE

Author keywords

Helicobacter pylori; Recurrence; Reinfection; Therapy

Indexed keywords

AMOXICILLIN; BISMUTH CITRATE; CARBON 13; METRONIDAZOLE; RANITIDINE; UREASE;

ADOLESCENT; ARTICLE; BACTERIAL INFECTION; BREATH ANALYSIS; CALCULATION; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; ENDOSCOPY; ESTONIA; FEMALE; FOLLOW UP; GASTROINTESTINAL ENDOSCOPY; GASTROINTESTINAL INFECTION; GASTROSCOPY; HELICOBACTER PYLORI; HISTOLOGY; HUMAN; MALE; NONHUMAN; PORPHYRIA; PREVALENCE; PRIORITY JOURNAL; RECURRENCE RISK; RECURRENT DISEASE; REINFECTION; SIDE EFFECT; TIME SERIES ANALYSIS; URINALYSIS;

ADOLESCENT; AMOXICILLIN; ANTI-BACTERIAL AGENTS; CHILD; ESTONIA; FEMALE; FOLLOW-UP STUDIES; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; METRONIDAZOLE; ORGANOMETALLIC COMPOUNDS; RECURRENCE; TIME FACTORS;

EID: 10644289180     PISSN: 00365521     EISSN: None     Source Type: Journal    
DOI: 10.1080/00365520410003461     Document Type: Article

References (57)

1. Kuipers EJ, Thijs JC, Festen HP. The prevalence of Helicobacter pylori in peptic ulcer disease. Aliment Pharmacol Ther 1995;9 Suppl 2:59-69.
2. Danesh J. Helicobacter pylori infection and gastric cancer: systematic review of the epidemiological studies. Aliment Pharmacol Ther 1999;13:851-6.
3. Helicobacter and Cancer Collaborative Group. Gastric cancer and Helicobacter pylori: a combined analysis of 12 case control studies nested within prospective cohorts. Gut 2001;49:347-53.
4. Valle J, Seppälä K, Sipponen P, Kosunen T. Disappearance of gastritis after eradication of Helicobacter pylori. A morphometric study. Scand J Gastroenterol 1991;26:1057-65.
5. Ohkusa T, Fujiki K, Takashimizu I, Kumagai J, Tanizawa T, Eishi Y, et al. Improvement in atrophic gastritis and intestinal metaplasia in patients in whom Helicobacter pylori was eradicated. Ann Intern Med 2001;134:380-6.
6. Kokkola A, Sipponen P, Rautelin H, Härkonen M, Kosunen TU, Haapiainen R, et al. The effect of Helicobacter pylori eradication on the natural course of atrophic gastritis with dysplasia. Aliment Pharmacol Ther 2002;16:515-20.
7. Ford A, Delaney B, Forman D, Moayyedi P. Eradication therapy for peptic ulcer disease in Helicobacter pylori positive patients. Cochrane Database Syst Rev 2003. p. CD003840.
8. Sipponen P. Gastric cancer: pathogenesis, risks, and prevention. J Gastroenterol 2002;37 Suppl 13:39-44.
9. Laheij RJ, Rossum LG, Jansen JB, Straatman H, Verbeek AL. Evaluation of treatment regimens to cure Helicobacter pylori infection: a meta-analysis. Aliment Pharmacol Ther 1999;13: 857-64.
10. Knippig C, Arand F, Leodolter A, Nilius M, Bayerdorffer E, Klein U, et al. Prevalence of H. pylori-infection in family members of H. pylori positive and its influence on the reinfection rate after successful eradication therapy: a two-year follow-up. Z Gastroenterol 2002;40:383-7.
11. Ramirez-Ramos A, Gilman RH, Leon-Barua R, Recavarren-Arce S, Watanabe J, Salazar G, et al. Rapid recurrence of Helicobacter pylori infection in Peruvian patients after successful eradication. Clin Infect Dis 1997;25:1027-31.
12. Bell GD, Powell KU, Burridge SM, Harrison G, Rameh B, Weil J, et al. Helicobacter pylori eradication: efficacy and side effect profile of a combination of omeprazole, amoxycillin and metronidazole compared with four alternative regimens. Q J Med 1993;86:743-50.
13. Borody TJ, Andrews P, Mancuso N, McCauley D, Jankiewicz E, Ferch N, et al. Helicobacter pylori reinfection rate, in patients with cured duodenal ulcer. Am J Gastroenterol 1994;89:529-32.
14. Forbes GM, Glaser ME, Cullen DJ, Warren JR, Christiansen KJ, Marshall BJ, et al. Duodenal ulcer treated with Helicobacter pylori eradication: seven-year follow-up. Lancet 1994;343:258-60.
15. Berstad A, Hatlebakk JG, Wilhelmsen I, Berstad K, Bang CJ, Nysaeter G, et al. Follow-up on 242 patients with peptic ulcer disease one year after eradication of Helicobacter pylori infection. Hepatogastroenterology 1995;42:655-9.
16. Miehlke S, Lehn N, Meining A, Bastlein E, Mannes GA, Stolte M, et al. Helicobacter pylori reinfection is rare in peptic ulcer patients cured by antimicrobial therapy. Eur J Gastroenterol Hepatol 1996;8:1161-3.
17. van der Hulst RW, Rauws EA, Koycu B, Keller JJ, ten Kate FJ, Dankert J, et al. Helicobacter pylori reinfection is virtually absent after successful eradication. J Infect Dis 1997;176:196-200.
18. Adachi M, Mizuno M, Yokota K, Miyoshi M, Nagahara Y, Maga T, et al. Reinfection rate following effective therapy against Helicobacter pylori infection in Japan. J Gastroenterol Hepatol 2002;17:27-31.
19. Soto G, Bautista CT, Roth DE, Gilman RH, Velapatino B, Ogura M, et al. the Gastrointestinal Physiology Working Group in Peru. Helicobacter pylori reinfection is common in Peruvian adults after antibiotic eradication therapy. J Infect Dis 2003;188:1263-75.
20. Coelho LG, Passos MC, Chausson Y, Costa EL, Maia AF, Brandao MJ, et al. Duodenal ulcer and eradication of Helicobacter pylori in a developing country. An 18-month follow-up study. Scand J Gastroenterol 1992;27:362-6.
21. Hildebrand P, Bardhan P, Rossi L, Parvin S, Rahman A, Arefin MS, et al. Recrudescence and reinfection with Helicobacter pylori after eradication therapy in Bangladeshi adults. Gastroenterology 2001;121:792-8.
22. Kepekci Y, Kadayifci A. Does the eradication of Helicobacter pylori cure duodenal ulcer disease in communities with a high prevalence rate? Comparison with long-term acid suppression. Int J Clin Pract 1999;53:505-8.
23. Mitchell HM, Hu P, Chi Y, Chen MH, Li YY, Hazell SL. A low rate of reinfection following effective therapy against Helicobacter pylori in a developing nation (China). Gastroenterology 1998;114:256-61.
24. Malaty HM, El-Kasabany A, Graham DY, Miller CC, Reddy SG, Srinivasan SR, et al. Age at acquisition of Helicobacter pylori infection: a follow-up study from infancy to adulthood. Lancet 2002;359:931-5.
25. Feydt-Schmidt A, Kindermann A, Konstantopoulos N, Demmelmair H, Ballauff A, Findeisen A, et al. Reinfection rate in children after successful Helicobacter pylori eradication. Eur J Gastroenterol Hepatol 2002;14:1119-23.
26. Kato S, Abukawa D, Furuyama N, Iinuma K. Helicobacter pylori reinfection rates in children after eradication therapy. J Pediatr Gastroenterol Nutr 1998;27:543-6.
27. Rowland M, Kumar D, Daly L, O'Connor P, Vaughan D, Drumm B. Low rates of Helicobacter pylori reinfection in children. Gastroenterology 1999;117:336-41.
28. Vorobjova T, Grünberg H, Oona M, Maaroos HI, Nilsson I, Wadström T, et al. Seropositivity to Helicobacter pylori and CagA protein in schoolchildren of different ages living in urban and rural areas in southern Estonia. Eur J Gastroenterol Hepatol 2000;12:97-101.
29. Lindkvist P, Tammur R, Nilsson I, Wretlind B, Giescke J. Helicobacler pylori infection in Estonia: a three-year follow-up of children from birth. In: Lindkvist P. Risk factors for infection with Helicobacter pylori [dissertation], Stockholm: Karolinska Institutet; 1999. p. 37.
30. Dixon MF, Genta RM, Yardley JH, Correa P. Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994. Am J Surg Pathol 1996;20:1161-81.
31. Herbarth O, Krumbiegel P, Fritz GJ, Richter M, Schlink U, Muller DM, et al. Helicobacter pylori prevalences and risk factors among school beginners in a German urban center and its rural county. Environ Health Perspect 2001;109:573-7.
32. Grimm W, Fischbach W. Helicobacter pylori-Infektion bei Kindern und Jugendlichen. Eine epidemiologische Untersuchung zu Prävalenz, sozioökonomischen Faktoren und Beschwerdebild. Dtsch Med Wochenschr 2003;128:1878-83.
33. Miyaji H, Azuma T, Ito S, Abe Y, Gejyo F, Hashimoto N, et al. Helicobacter pylori infection occurs via close contact with infected individuals in early childhood. J Gastroenterol Hepatol 2000;15:257-62.
34. Murray LJ, McCrum EE, Evans AE, Bamford KB. Epidemiology of Helicobacter pylori infection among 4742 randomly selected subjects from Northern Ireland. Int J Epidemiol 1997;26:880-7.
35. Maaroos HI, Keevallik R, Kolk H, Kull I, Labotkin K, Suurmaa K, et al. Helicobacter pylori infektsiooniga seotud peptilise haavandi ravi uus kontseptsioon. Eesti Arst 2001;80:68-74.
36. Gabryelewicz A, Laszewicz W, Dzieniszewski J, Ciok J, Marlicz K, Bielecki D, et al. Multicenter evaluation of dual-therapy (omeprazol and amoxycillin) for Helicobacter pylori-associated duodenal and gastric ulcer (two years of the observation). J Physiol Pharmacol 1997;48 Suppl 4:93-105.
37. Ni YH, Lin JT, Huang SF, Yang JC, Chang MH. Accurate diagnosis of Helicobacter pylori infection by stool antigen test and 6 other currently available tests in children. J Pediatr 2000; 136:823-7.
38. Rowland M, Lambert I, Gormally S, Daly LE, Thomas JE, Hetherington C, et al. Carbon 13-labeled urea breath test for the diagnosis of Helicobacter pylori infection in children. J Pediatr 1997;131:815-20.
39. 13C-urea breath test threshold calculation and evaluation for the detection of Helicobacter pylori infection in children. BMC Gastroenterol 2002;2:12.
40. 13C-urea breath test for childhood Helicobacter pylori infection: a multicenter Japanese study. Am J Gastroenterol 2002;97:1668-73.
41. 13C-urea breath test results in children. J Pediatr Gastroenterol Nutr 2000;30:85-91.
42. 13C-urea breath test for the diagnosis of Helicobacter pylori infection in children: a multicenter study. Am J Gastroenterol 2000;95:646-50.
43. Cutler AF, Schubert TT. Long-term Helicobacter pylori recurrence after successful eradication with triple therapy. Am J Gastroenterol 1993;88:1359-61.
44. Gisbert JP, Pajares JM, Garcia-Valriberas R, Abraira V, Boixeda D, Garcia-Gravalos R, et al. Recurrence of Helicobacter pylori infection after eradication: incidence and variables influencing it. Scand J Gastroenterol 1998;33:1144-51.
45. Rollan A, Giancaspero R, Fuster F, Acevedo C, Figueroa C, Hola K, et al. The long-term reinfection rate and the course of duodenal ulcer disease after eradication of Helicobacter pylori in a developing country. Am J Gastroenterol 2000;95:50-6.
46. Bell GD, Powell KU. Helicobacter pylori reinfection after apparent eradication: the Ipswich experience. Scand J Gastroenterol 1996;Suppl 215:96-104.
47. Rothenbacher D, Bode G, Brenner H. Dynamics of Helicobacter pylori infection in early childhood in a high-risk group living in Germany: loss of infection higher than acquisition. Aliment Pharmacol Ther 2002;16:1663-8.
48. Triantafillidis JK, Gikas A, Apostolidiss N, Merikas E, Mallass E, Peros G. The low prevalence of Helicobacter infection in patients with inflammatory bowel disease could be attributed to previous antibiotic treatment. Am J Gastroenterol 2003;98: 1213-4.
49. Leung WK, Hung LC, Kwok CK, Leong RW, Ng DK, Sung JJ. Follow up of serial urea breath test results in patients after consumption of antibiotics for non-gastric infections. World J Gastroenterol 2002;8:703-6.
50. Sherman P, Hassall E, Hunt RH, Fallone CA, Veldhuyzen Van Zanten S, Thomson AB. Canadian Helicobacter study group consensus conference on the approach to Helicobacter pylori infection in children and adolescents. Can J Gastroenterol 1999; 13:553-9.
51. Drumm B, Koletzko S, Oderda G. Helicobacter pylori infection in children: a consensus statement. European Paediatric Task Force on Helicobacter pylori. J Pediatr Gastroenterol Nutr 2000; 30:207-13.
52. Gold BD, Colletti RB, Abbott M, Czinn SJ, Elitsur Y, Hassall E, et al. North American Society for Pediatric Gastroenterology and Nutrition. Helicobacter pylori infection in children: recommendations for diagnosis and treatment. J Pediatr Gastroenterol Nutr 2000;31:490-7.
53. Wewer V, Andersen LP, Paerregaard A, Gernow A, Hansen JP, Matzen P, et al. Treatment of Helicobacter pylori in children with recurrent abdominal pain. Helicobacter 2001;6:244-8.
54. Bode G, Brenner H, Adler G, Rothenbacher D. Recurrent abdominal pain in children. Evidence from a population-based study that social and familial factors play a major role but not Helicobacter pylori infection. J Psychosom Res 2003;54:417-21.
55. Imrie C, Rowland M, Bourke B, Drumm B. Is Helicobacter pylori infection in childhood a risk factor for gastric cancer? Pediatrics 2001;107:373-80.
56. Forbes GM, Threlfall TJ. Treatment of Helicobacter pylori infection to reduce gastric cancer incidence: uncertain benefits of a community-based programme in Australia. J Gastroenterol Hepatol 1998;13:1091-5.
57. Oona M, Utt M, Nilsson I, Uibo O, Vorobjova T, Maaroos HI. Helicobacter pylori infection in children in Estonia: decreasing seroprevalence during the 11-year period of profound socioeconomic changes. Helicobacter 2004;9:233-41.